MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-25-2025
The Scotts Miracle-Gro Company Cost of Revenue 2011-2025 | SMG
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue The Scotts Miracle-Gro Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.35 B | 2.62 B | 2.71 B | 2.89 B | 3.43 B | 2.77 B | 2.13 B | 1.78 B | 1.67 B | 1.6 B | 1.56 B | 1.69 B | 1.79 B | 1.81 B | 1.77 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.43 B | 1.56 B | 2.17 B |
Quarterly Cost of Revenue The Scotts Miracle-Gro Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 806 M | 866 M | 317 M | - | 851 M | 987 M | 354 M | - | 880 M | 1 B | 421 M | 2.42 B | 884 M | 1.08 B | 549 M | 2.82 B | 1.11 B | 1.16 B | - | 2.09 B | 954 M | 829 M | 311 M | 1.72 B | 747 M | 311 M | 261 M | 1.43 B | 636 M | 261 M | 188 M | 1.38 B | 590 M | 188 M | 171 M | 1.53 B | 636 M | 203 M | - | 1.53 B | 722 M | 647 M | 187 M | 1.5 B | 693 M | 187 M | 156 M | 1.49 B | 695 M | 162 M | 175 M | 1.57 B | 686 M | 175 M | 174 M | 1.5 B | 658 M | 186 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.82 B | 156 M | 816 M |
Cost of Revenue of other stocks in the Agricultural inputs industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bioceres Crop Solutions Corp.
BIOX
|
119 M | $ 1.58 | 0.32 % | $ 435 M |  Argentina |
 |
ICL Group Ltd
ICL
|
4.34 B | $ 4.96 | -2.17 % | $ 7.83 B |  Israel |
 |
China Green Agriculture
CGA
|
58.2 M | - | 0.51 % | $ 27.6 M |  China |
 |
Nutrien Ltd.
NTR
|
17.5 B | $ 61.86 | -1.56 % | $ 34.8 B |  Canada |
 |
CF Industries Holdings
CF
|
3.88 B | $ 78.41 | -0.98 % | $ 14.1 B |  USA |
 |
Arcadia Biosciences
RKDA
|
3.3 M | $ 3.7 | 1.65 % | $ 4.58 M | USA |
 |
FMC Corporation
FMC
|
2.6 B | $ 13.01 | -6.47 % | $ 1.63 B | USA |
 |
Origin Agritech Limited
SEED
|
33.6 M | $ 1.36 | -5.56 % | $ 7.64 M | China |
 |
CVR Partners, LP
UAN
|
406 M | $ 94.92 | -0.46 % | $ 1 B | USA |
 |
Corteva
CTVA
|
9.53 B | $ 65.56 | -0.85 % | $ 45.5 B | USA |
 |
American Vanguard Corporation
AVD
|
427 M | $ 4.07 | -5.9 % | $ 114 M | USA |
 |
Marrone Bio Innovations
MBII
|
17.1 M | - | -5.9 % | $ 180 M | USA |
 |
The Mosaic Company
MOS
|
9.61 B | $ 24.88 | -5.07 % | $ 7.96 B | USA |